Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142083 |
| CAS No | 26687-79-6 |
| Mol.F. | C6H10N4O2 |
| Mol.Wt. | 170.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142084 |
| CAS No | NA |
| Mol.F. | C22H18N6O5S2 |
| Mol.Wt. | 510 .54g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142085 |
| CAS No | NA |
| Mol.F. | C16H13ClN2O2 |
| Mol.Wt. | 300.7 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142086 |
| CAS No | NA |
| Mol.F. | C16H13N3O4 |
| Mol.Wt. | 311.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142087 |
| CAS No | NA |
| Mol.F. | C16H15N3O2 |
| Mol.Wt. | 281.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142088 |
| CAS No | NA |
| Mol.F. | C11H10N4O3S |
| Mol.Wt. | 278.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142089 |
| CAS No | NA |
| Mol.F. | C8H7N5O |
| Mol.Wt. | 189.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142090 |
| CAS No | 2619509-30-5 |
| Mol.F. | C9H10N2O3S |
| Mol.Wt. | 226.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142091 |
| CAS No | NA |
| Mol.F. | C9H21N3O |
| Mol.Wt. | 187.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142092 |
| CAS No | NA |
| Mol.F. | C17H16N6O3 |
| Mol.Wt. | 352.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142093 |
| CAS No | NA |
| Mol.F. | C5H10N2O5S |
| Mol.Wt. | 210.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142094 |
| CAS No | NA |
| Mol.F. | C4H10N204 |
| Mol.Wt. | 182.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142095 |
| CAS No | NA |
| Mol.F. | C18H27N3O5 |
| Mol.Wt. | 365.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142096 |
| CAS No | NA |
| Mol.F. | C15H18N2O5 |
| Mol.Wt. | 306.12 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142097 |
| CAS No | NA |
| Mol.F. | C16H23N3O5 |
| Mol.Wt. | 337.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142098 |
| CAS No | NA |
| Mol.F. | C12H14N2O4 |
| Mol.Wt. | 250.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |